Specific disease-modifying therapies (DMTs) significantly slow the rate of brain volume loss in adults with multiple sclerosis (MS), a benefit that is directly linked to reduced long-term disability, according to a new review. A network meta-analysis of more than 26,000 patients confirms that therapies most effective at preserving brain tissue are also those that can […]
The post DMTs that protect brain volume may also slow disability progression appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com